Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May 10;40(14):1596-1597.
doi: 10.1200/JCO.21.02904. Epub 2022 Mar 8.

Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti-PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial

Affiliations
Free article
Comment

Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti-PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial

Timothée Olivier et al. J Clin Oncol. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Vinay PrasadConsulting or Advisory Role: UnitedHealthcareSpeakers' Bureau: Evicore, New Century HealthResearch Funding: Arnold VenturesPatents, Royalties, Other Intellectual Property: I receive Royalties from my book Ending Medical Reversal, I am a paid writer for Medscape, I received an advance for a book entitled: Malignant Johns Hopkins Press, I make a podcast called Plenary Session and we have backers on Patreon, these are individuals who contribute for us to make the podcast, I receive royalties from my book Malignant, I am a paid writer for MedPageNo other potential conflicts of interest were reported.

Comment in

  • Reply to T. Olivier et al.
    Wolchok JD, Kluger H, Campigotto F, Larkin J, Hodi FS. Wolchok JD, et al. J Clin Oncol. 2022 May 10;40(14):1597-1598. doi: 10.1200/JCO.22.00209. Epub 2022 Mar 8. J Clin Oncol. 2022. PMID: 35258992 Free PMC article. No abstract available.

Comment on

  • Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
    Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Butler MO, Hill A, Márquez-Rodas I, Haanen JBAG, Guidoboni M, Maio M, Schöffski P, Carlino MS, Lebbé C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bas T, Ritchings C, Larkin J, Hodi FS. Wolchok JD, et al. J Clin Oncol. 2022 Jan 10;40(2):127-137. doi: 10.1200/JCO.21.02229. Epub 2021 Nov 24. J Clin Oncol. 2022. PMID: 34818112 Free PMC article. Clinical Trial.